Illuminare
1 known investors
Illuminare Biotechnologies is a clinical-stage biotechnology company developing Illuminare-1, a small-molecule fluorescent agent that helps surgeons visualize nerves in real time during operations to reduce the risk of nerve damage. The compound offers immediate onset and sustained nerve illumination, and has completed a first-in-human trial in radical prostatectomy.
BiotechHealthtechMedical Devices
Investors · 1
Frequently asked questions
- What does Illuminare do?
- Illuminare Biotechnologies is a clinical-stage biotechnology company developing Illuminare-1, a small-molecule fluorescent agent that helps surgeons visualize nerves in real time during operations to reduce the risk of nerve damage. The compound offers immediate onset and sustained nerve illumination, and has completed a first-in-human trial in radical prostatectomy.
- Who are Illuminare's investors?
- Illuminare's investors include Band of Angels.